Emergency identification and treatment of acute ischemic stroke.

[1]  J. Grotta.  Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. , 1997, Stroke.

[2]  M Fisher,et al.  Evolving stroke and the ischemic penumbra , 1996, Neurology.

[3]  G. Hankey,et al.  Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, JAMA.

[4]  M. Hommel,et al.  Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.

[5]  J. Grotta,et al.  Treatment of experimental focal ischemia in rats with lubeluzole , 1996, Neuropharmacology.

[6]  M. Fisher,et al.  The effects of prolonged treatment with citicoline in temporary experimental focal ischemia , 1996, Journal of the Neurological Sciences.

[7]  H. D'Arceuil,et al.  Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient. , 1996, Stroke.

[8]  V Beaudouin,et al.  Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.

[9]  R R Edelman,et al.  Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  H. Diener,et al.  Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. , 1996, Stroke.

[11]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[12]  L. Munari,et al.  RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE , 1995 .

[13]  J. Broderick,et al.  Emergency physicians. Accuracy in the diagnosis of stroke. , 1995, Stroke.

[14]  J. Alvir,et al.  Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. , 1995, Archives of neurology.

[15]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[16]  M Fisher,et al.  New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.

[17]  W. S. Thomas,et al.  Effect of Tirilazad Mesylate on Middle Cerebral Artery Occlusion/Reperfusion in Nonhuman Primates , 1995 .

[18]  K. J. D'Orlando,et al.  Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury. , 1995, Neurological research.

[19]  J. Broderick,et al.  Frequency and accuracy of prehospital diagnosis of acute stroke. , 1995, Stroke.

[20]  R. Rothlein,et al.  Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.

[21]  J. Grotta,et al.  Current emergency department management of stroke in Houston, Texas. , 1995, Stroke.

[22]  J. Broderick,et al.  Urgent Therapy for Acute Stroke: Effects of a Stroke Trial on Untreated Patients , 1994, Stroke.

[23]  K. Hossmann.  Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[24]  M. Malkoff,et al.  Code stroke. An attempt to shorten inhospital therapeutic delays. , 1994, Stroke.

[25]  K. Lees,et al.  Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers. , 1994, British journal of clinical pharmacology.

[26]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[27]  J. Grotta.  The Current Status of Neuronal Protective Therapy: Why Have All Neuronal Protective Drugs Worked in Animals but None So Far in Stroke Patients? , 1994 .

[28]  J. Rothrock,et al.  Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. , 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[29]  L. Brass,et al.  Factors Associated With Early Presentation of Acute Stroke , 1993, Stroke.

[30]  J. Broderick,et al.  Time of hospital presentation in patients with acute stroke. , 1993, Archives of internal medicine.

[31]  H. Anderson,et al.  Thrombolysis in acute myocardial infarction. , 1993, The New England journal of medicine.

[32]  J. Broderick,et al.  Blood pressure during the first minutes of focal cerebral ischemia. , 1993, Annals of emergency medicine.

[33]  J. Grotta,et al.  Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. , 1993, Archives of neurology.

[34]  M. Small,et al.  Denial of Illness in Stroke , 1993, Stroke.

[35]  M. Malkoff,et al.  Delay between emergency room arrival and stroke consultation. , 1993, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[36]  J. Ornato,et al.  Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group. , 1992, Annals of emergency medicine.

[37]  K Minematsu,et al.  Reversible Focal Ischemic Injury Demonstrated by Diffusion‐Weighted Magnetic Resonance Imaging in Rats , 1992, Stroke.

[38]  J. Ritter.  Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group. , 1992, Stroke.

[39]  L. Wilkins.  Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .

[40]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[41]  M. Alberts,et al.  An analysis of time of presentation after stroke. , 1990, JAMA.

[42]  E. Ruiz,et al.  An analysis of time delays preceding thrombolysis for acute myocardial infarction. , 1989, JAMA.

[43]  J. Marler,et al.  Early treatment for acute ischemic stroke. , 1989, Annals of internal medicine.